
The Department of Justice (DOJ) has stepped up its investigation of Google’s proposed US$2.1 billion acquisition of Fitbit, a deal that critics say could pose increased threats to customer privacy, two sources close to the situation told The Post.
In a move that typically signals increased scrutiny for a merger, regulators are now conducting a so-called second request review, asking for more documents and taking additional time to investigate the deal, the sources said.
Assistant Attorney General Makan Delrahim, who heads the DOJ’s antitrust division, has recused himself from the case because of his past history as a lobbyist working for Alphabet’s Google.
Now, it is the Attorney General William Barr who is issuing civil investigative demands (CIDs) to parties in the investigation and will be more directly involved in the review than he would be normally, sources said.
Barr told the Wall Street Journal in a March 23 article that his investigation of Google’s overall anti-competitive behavior in suppressing competition would be wrapped up by early summer.
“One would think Google would be a lower priority for the government until Corona clears,” Seth Bloom of Bloom Strategic Counsel told The Post. “But given Barr’s statement, it seems like he hasn’t been deterred.”
Full Content: New York Post
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Federal Court to Hear Case on Trump’s Firing of FTC Democrats
May 20, 2025 by
CPI
UK Government Suffers Third Successive Defeat on Data (Use and Access) Bill
May 20, 2025 by
CPI
Sex Toy Retailer Says Google Breaches EU Digital Market Rules
May 20, 2025 by
CPI
Latham & Watkins Expands Brussels Antitrust Team
May 20, 2025 by
CPI
Brazil’s Antitrust Watchdog Expected to Approve Pet Retail Merger Without Conditions
May 20, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas